Partner Harvey Kesner Joins Client ChromaDex Corp. at NASDAQ Opening Bell Ceremony
Press Release – New York, NY – May 9, 2016 – Sichenzia Ross Friedman Ference LLP partner Harvey Kesner joined representatives of client ChromaDex Corp. including Frank L. Jaksch, Chief Executive Officer, Tom Varvaro, Chief Financial Officer, and Troy Rhonemus, Chief Operating Officer, at the NASDAQ MarketSite in Times Square to ring the May 6 opening bell. Also present at the opening ceremony was former Chromadex employee Jordan Kesner, Masters in Biotechnology and currently a Ph.D. candidate in Systems Biology at Columbia University.
ChromaDex Corp. is an innovator of proprietary health, wellness, and nutritional ingredients that creates science-based solutions for dietary supplement, food and beverage, skin care, sports nutrition, and pharmaceutical products. The company’s common stock has traded on The Nasdaq Capital Market under the symbol “CDXC” since April 25, 2016.
Visit SRFK's LinkedIn page
Latest posts by Sichenzia Ross Ference Kesner LLP (see all)
- Attorney - July 17, 2017
- Partner Harvey Kesner Rings Nasdaq Opening Bell with Laidlaw & Company (UK) Ltd. and Therapix Biosciences Ltd. - June 28, 2017
- Sichenzia Ross Ference Kesner LLP Represents Rodman & Renshaw a unit of H.C Wainwright in a$7.4 Million Public Offering of Medical Transcript Billing, Corp. - June 28, 2017